Found 5 hits for monomerid = 50515754 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50515754
(CHEMBL4448759)Show SMILES CC(C)c1cc(C(C)C)c(c(c1)C(C)C)S(=O)(=O)N1CCN(Cn2cc3c(n2)c2ccccc2oc3=O)CC1 Show InChI InChI=1S/C30H38N4O4S/c1-19(2)22-15-24(20(3)4)29(25(16-22)21(5)6)39(36,37)34-13-11-32(12-14-34)18-33-17-26-28(31-33)23-9-7-8-10-27(23)38-30(26)35/h7-10,15-17,19-21H,11-14,18H2,1-6H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
School of Traditional Chinese Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of PI3Kgamma (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay |
Eur J Med Chem 182: (2019)
Article DOI: 10.1016/j.ejmech.2019.111630 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50515754
(CHEMBL4448759)Show SMILES CC(C)c1cc(C(C)C)c(c(c1)C(C)C)S(=O)(=O)N1CCN(Cn2cc3c(n2)c2ccccc2oc3=O)CC1 Show InChI InChI=1S/C30H38N4O4S/c1-19(2)22-15-24(20(3)4)29(25(16-22)21(5)6)39(36,37)34-13-11-32(12-14-34)18-33-17-26-28(31-33)23-9-7-8-10-27(23)38-30(26)35/h7-10,15-17,19-21H,11-14,18H2,1-6H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 420 | n/a | n/a | n/a | n/a | n/a | n/a |
School of Traditional Chinese Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of PI3Kdelta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay |
Eur J Med Chem 182: (2019)
Article DOI: 10.1016/j.ejmech.2019.111630 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50515754
(CHEMBL4448759)Show SMILES CC(C)c1cc(C(C)C)c(c(c1)C(C)C)S(=O)(=O)N1CCN(Cn2cc3c(n2)c2ccccc2oc3=O)CC1 Show InChI InChI=1S/C30H38N4O4S/c1-19(2)22-15-24(20(3)4)29(25(16-22)21(5)6)39(36,37)34-13-11-32(12-14-34)18-33-17-26-28(31-33)23-9-7-8-10-27(23)38-30(26)35/h7-10,15-17,19-21H,11-14,18H2,1-6H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
School of Traditional Chinese Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of PI3Kbeta (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay |
Eur J Med Chem 182: (2019)
Article DOI: 10.1016/j.ejmech.2019.111630 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50515754
(CHEMBL4448759)Show SMILES CC(C)c1cc(C(C)C)c(c(c1)C(C)C)S(=O)(=O)N1CCN(Cn2cc3c(n2)c2ccccc2oc3=O)CC1 Show InChI InChI=1S/C30H38N4O4S/c1-19(2)22-15-24(20(3)4)29(25(16-22)21(5)6)39(36,37)34-13-11-32(12-14-34)18-33-17-26-28(31-33)23-9-7-8-10-27(23)38-30(26)35/h7-10,15-17,19-21H,11-14,18H2,1-6H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
School of Traditional Chinese Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of PI3Kalpha (unknown origin) using diC8-PI(4,5)P2 as substrate incubated for 3 hrs in presence of ATP by fluorescence polarization assay |
Eur J Med Chem 182: (2019)
Article DOI: 10.1016/j.ejmech.2019.111630 |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM50515754
(CHEMBL4448759)Show SMILES CC(C)c1cc(C(C)C)c(c(c1)C(C)C)S(=O)(=O)N1CCN(Cn2cc3c(n2)c2ccccc2oc3=O)CC1 Show InChI InChI=1S/C30H38N4O4S/c1-19(2)22-15-24(20(3)4)29(25(16-22)21(5)6)39(36,37)34-13-11-32(12-14-34)18-33-17-26-28(31-33)23-9-7-8-10-27(23)38-30(26)35/h7-10,15-17,19-21H,11-14,18H2,1-6H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
School of Traditional Chinese Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of mTOR (unknown origin) |
Eur J Med Chem 182: (2019)
Article DOI: 10.1016/j.ejmech.2019.111630 |
More data for this Ligand-Target Pair | |